Goldcorp Inc. (USA) (NYSE:GG) has resumed operations at its Los Filos mine in Mexico after reaching a new five-year occupancy agreement with local landowners, the company said on Monday. Goldcorp Inc. (USA) (NYSE:GG) shares after opening at $25.50 moved to $25.57 on last trade day and at the end of the day closed at $25.34. Company price to sales ratio in past twelve months was calculated as 5.60 and price to cash ratio as 33.05. Goldcorp Inc. (USA) (NYSE:GG) showed a positive weekly performance of 3.43%.
An investigation on behalf of investors, who currently hold shares of Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) shares, was announced concerning whether the takeover of Questcor Pharmaceuticals Inc. by Mallinckrodt plc for a value of approximately $86.10 per share is unfair to NASDAQ:QCOR stockholders. Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) shares advanced 0.12% in last trading session and ended the day on $83.15. QCOR return on equity ratio is recorded as 86.50% and its return on assets is 46.90%. Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) yearly performance is 147.99%.
BlackBerry Ltd. (NASDAQ:BBRY) (TSE:BB) continues to lose subscribers in the United States, according to the latest survey released by comScore, a global digital measurement and analytics firm that provides insights regarding web, mobile, and TV consumers. BlackBerry Ltd (NASDAQ:BBRY) shares moved down -2.70% in last trading session and was closed at $7.93, while trading in range of $7.81 – $8.13. BlackBerry Ltd (NASDAQ:BBRY) year to date (YTD) performance is 6.59%.
Regeneron Pharmaceuticals Inc. logo Analysts at Robert W. Baird raised their price objective on shares of Regeneron Pharmaceuticals (NASDAQ:REGN) from $362.00 to $368.00 in a research report issued to clients and investors on Monday. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) weekly performance is 6.30%. On last trading day company shares ended up $298.98. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) distance from 50-day simple moving average (SMA50) is -4.47%. Analysts mean target price for the company is $344.25.